Heather L Armstrong1,2, Julian Gitelman3, Zishan Cui1, Nicanor Bacani1, Paul Sereda1, Nathan J Lachowsky1,4, Kiffer G Card1,4, Jordan M Sang1, Henry F Raymond5, Julio Montaner1,6, David Hall7, Terry Howard8, Mark Hull1,6, Robert S Hogg1,9, Eric A Roth1,10, David M Moore1,6. 1. British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada. 2. Department of Psychology, University of Southampton, Southampton, United Kingdom. 3. Faculty of Medicine, University of Toronto, Toronto, Canada. 4. School of Public Health and Social Policy, University of Victoria, Victoria, Canada. 5. School of Public Health, Rutgers University, Piscataway, New Jersey, United States of America. 6. Faculty of Medicine, University of British Columbia, Vancouver, Canada. 7. Immunodeficiency Clinic, St. Paul's Hospital, Vancouver, Canada. 8. Momentum Health Study, Community Advisory Board, Vancouver, Canada. 9. Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada. 10. Department of Anthropology, University of Victoria, Victoria, Canada.
Abstract
INTRODUCTION: In 2010, British Columbia (BC) implemented HIV Treatment as Prevention (TasP) as policy. We examined trends in virologic suppression and determinants of significant viremia among a prospective biobehavioural cohort of men who have sex with men (gbMSM) in Vancouver from 2012-2017. METHODS: Respondent-driven sampling was used to recruit sexually active gbMSM (≥16 years) who completed biannual study visits with a computer-assisted self-interview and clinical CD4 and viral load (VL) testing. We linked participant data with the BC HIV Drug Treatment Program to obtain antiretroviral dispensing and VL data. We conducted a trend analysis of VL suppression using univariable generalized estimating equation (GEE) multi-level modelling and multivariable GEE to identify factors associated with episodes of VL ≥200 copies/mL. RESULTS: Of 774 participants, 223 were living with HIV at baseline and 16 were diagnosed during follow-up (n = 239). We observed a significant trend towards reduced levels of unsuppressed VL (>200 copies/mL) from 22% (07/2012-12/2012) to 12% (07/2016-12/2016) (OR:0.87; 95%CI:0.83-0.91 for each 6-month period). Among those with at least one follow-up visit, (n = 178, median follow-up = 3.2 years, median age = 46.9 years), younger age (aOR:0.97; 95%CI:0.94-0.99, per year), ecstasy use (aOR:1.69; 95%CI:1.13-2.53), crystal methamphetamine use (aOR:1.71; 95%CI:1.18-2.48), seeking sex via websites (aOR:1.46; 95%CI:1.01-2.12), and lower HIV treatment optimism (aOR:0.94; 95%CI:0.90-0.97) were associated with episodes of elevated viremia. CONCLUSIONS: During a period when TasP policy was actively promoted, we observed a significant trend towards reduced levels of unsuppressed VL. Continued efforts should promote HIV treatment optimism and engagement, especially among younger gbMSM and those who use ecstasy and crystal methamphetamine.
INTRODUCTION: In 2010, British Columbia (BC) implemented HIV Treatment as Prevention (TasP) as policy. We examined trends in virologic suppression and determinants of significant viremia among a prospective biobehavioural cohort of men who have sex with men (gbMSM) in Vancouver from 2012-2017. METHODS: Respondent-driven sampling was used to recruit sexually active gbMSM (≥16 years) who completed biannual study visits with a computer-assisted self-interview and clinical CD4 and viral load (VL) testing. We linked participant data with the BC HIV Drug Treatment Program to obtain antiretroviral dispensing and VL data. We conducted a trend analysis of VL suppression using univariable generalized estimating equation (GEE) multi-level modelling and multivariable GEE to identify factors associated with episodes of VL ≥200 copies/mL. RESULTS: Of 774 participants, 223 were living with HIV at baseline and 16 were diagnosed during follow-up (n = 239). We observed a significant trend towards reduced levels of unsuppressed VL (>200 copies/mL) from 22% (07/2012-12/2012) to 12% (07/2016-12/2016) (OR:0.87; 95%CI:0.83-0.91 for each 6-month period). Among those with at least one follow-up visit, (n = 178, median follow-up = 3.2 years, median age = 46.9 years), younger age (aOR:0.97; 95%CI:0.94-0.99, per year), ecstasy use (aOR:1.69; 95%CI:1.13-2.53), crystal methamphetamine use (aOR:1.71; 95%CI:1.18-2.48), seeking sex via websites (aOR:1.46; 95%CI:1.01-2.12), and lower HIV treatment optimism (aOR:0.94; 95%CI:0.90-0.97) were associated with episodes of elevated viremia. CONCLUSIONS: During a period when TasP policy was actively promoted, we observed a significant trend towards reduced levels of unsuppressed VL. Continued efforts should promote HIV treatment optimism and engagement, especially among younger gbMSM and those who use ecstasy and crystal methamphetamine.
Authors: Radha Rajasingham; Matthew J Mimiaga; Jaclyn M White; Megan M Pinkston; Rachel P Baden; Jennifer A Mitty Journal: AIDS Patient Care STDS Date: 2011-11-09 Impact factor: 5.078
Authors: Lina M C Nerlander; Brooke E Hoots; Heather Bradley; Dita Broz; Anna Thorson; Gabriela Paz-Bailey Journal: Drug Alcohol Depend Date: 2018-07-20 Impact factor: 4.492
Authors: Baligh R Yehia; Peter Rebeiro; Keri N Althoff; Allison L Agwu; Michael A Horberg; Hasina Samji; Sonia Napravnik; Kenneth Mayer; Ellen Tedaldi; Michael J Silverberg; Jennifer E Thorne; Ann N Burchell; Sean B Rourke; Anita Rachlis; Angel Mayor; Michael J Gill; Anne Zinski; Michael Ohl; Kathryn Anastos; Alison G Abraham; Mari M Kitahata; Richard D Moore; Kelly A Gebo Journal: J Acquir Immune Defic Syndr Date: 2015-04-01 Impact factor: 3.731
Authors: Sean P Colyer; David M Moore; Zishan Cui; Julia Zhu; Heather L Armstrong; Matthew Taylor; Joshua Edward; Terry Howard; Chad Dickie; Gbolahan Olarewaju; Julio S G Montaner; Robert S Hogg; Eric A Roth; Nathan J Lachowsky Journal: Subst Use Misuse Date: 2020-10-15 Impact factor: 2.164
Authors: Patrick A Wilson; Shoshana Y Kahana; Maria Isabel Fernandez; Gary W Harper; Kenneth Mayer; Craig M Wilson; Lisa B Hightow-Weidman Journal: JAMA Pediatr Date: 2016-02 Impact factor: 16.193
Authors: David M Moore; Zishan Cui; Shayna Skakoon-Sparling; Jordan Sang; Justin Barath; Lu Wang; Nathan Lachowsky; Joseph Cox; Gilles Lambert; Syed W Noor; Daniel Grace; Jody Jollimore; Herak Apelian; Allan Lal; Abbie Parlette; Trevor A Hart Journal: J Int AIDS Soc Date: 2021-04 Impact factor: 5.396